BLZE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Backblaze Inc (BLZE) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows mixed financial performance, bearish technical indicators, and a lack of strong positive catalysts. Analysts have downgraded their ratings and reduced price targets, reflecting concerns about slower growth and increased expenses. While options data suggests bullish sentiment, it is not enough to outweigh the broader concerns. A hold position is recommended until clearer growth trends or positive catalysts emerge.
The technical indicators for BLZE are bearish. The MACD is below zero and negatively expanding, indicating downward momentum. The RSI is at 33.676, which is neutral but nearing oversold territory. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below the key pivot level of 4.052, with support at 3.722 and resistance at 4.382.
The company reported strong Q4 adjusted EBITDA margins of 27.6% and signed the largest deal in its history with a 'neocloud' provider. Gross margin improved by 13.88% YoY to 62.37%.
Net income dropped significantly by -62.35% YoY, and EPS fell by -70%. Analysts have downgraded ratings and reduced price targets due to concerns over slower growth, increased capital expenditures, and margin pressure. Technical indicators are bearish, and there is no recent news or congress trading data to support a positive outlook.
In Q4 2025, Backblaze reported revenue growth of 11.77% YoY to $37.76M. However, net income dropped significantly to -$5.41M (-62.35% YoY), and EPS fell to -0.09 (-70% YoY). Gross margin improved to 62.37% (+13.88% YoY), but the overall financial performance reflects a mixed picture with slower growth and higher losses.
Analysts have mixed views, with multiple firms lowering their price targets. Craig-Hallum downgraded the stock to Hold with a $4.50 target, citing a soft FY 2026 outlook and increased capital expenditures. Other firms like Oppenheimer, B. Riley, and Needham maintain Buy ratings but have reduced price targets, reflecting concerns over slower growth and elongated deal timelines.
